Table 2.
Clinical characteristics of 76 patients (from case reports)
| Clinical Characteristics | Frequency (percent) |
|---|---|
| Year of publication | |
| - ≤ 2010 | 38 (50) |
| - > 2010 | 38 (50) |
| Age, mean (SD) | 30.1 (11.5) |
| Impaired consciousness | |
| - Yes | 21 (27.6) |
| - No | 25 (22.4) |
| Pulmonary edema | |
| - Yes | 3 (3.9) |
| - No | 73 (96.1) |
| Renal failure | |
| - Yes | 28 (36.8) |
| - No | 48 (63.2) |
| Severe anemia | |
| - Yes | 8 (10.5) |
| - No | 68 (89.5) |
| Bleeding | |
| - Yes | 8 (10.5) |
| - No | 68 (89.5) |
| Jaundice | |
| - Yes | 19 (25) |
| - No | 57 (75) |
| Acidosis | |
| - Yes | 4 (5.3) |
| - No | 72 (94.7) |
| Hyperparasitemia | |
| - Yes | 2 (2.6) |
| - No | 74 (97.4) |
| Respiratory distress | |
| - Yes | 22 (28.9) |
| - No | 54 (71.1) |
| Convulsion | |
| - Yes | 8 (10.5) |
| - No | 68 (89.5) |
| Prostration | |
| - Yes | 1 (1.3) |
| - No | 75 (98.7) |
| Gender | |
| - Male | 48 (64) |
| - Female | 27 (36) |
| Country of infection | |
| - India | 59 (77.6) |
| - Non-India | 17 (22.4) |
| Days of fever | 5.71 (2.58) |
| Cough | |
| - Yes | 6 (7.9) |
| - No | 70 (92.1) |
| Weakness | |
| - Yes | 9 (11.8) |
| - No | 67 (88.2) |
| Headache | |
| - Yes | 12 (15.8) |
| - No | 64 (84.2) |
| Malaise | |
| - Yes | 3 (3.9) |
| - No | 73 (96.1) |
| Rash | |
| - Yes | 7 (9.2) |
| - No | 69 (90.8) |
| Urine output abnormality | |
| - Yes | 19 (25) |
| - No | 57 (75) |
| Chills | |
| - Yes | 36 (47.4) |
| - No | 40 (52.6) |
| Rigors | |
| - Yes | 27 (35.5) |
| - No | 49 (64.5) |
| Abdominal pain | |
| - Yes | 15 (19.7) |
| - No | 61 (80.3) |
| Nausea | |
| - Yes | 6 (7.9) |
| - No | 70 (92.1) |
| Vomiting | |
| - Yes | 15 (19.7) |
| - No | 61 (80.3) |
| Edema | |
| - Yes | 1 (1.3) |
| - No | 75 (98.7) |
| Temperature, mean (SD) | 38.5 (1.04) |
| Systolic blood pressure, mean (SD) | 107.6 (24.5) |
| Diastolic blood pressure, mean (SD) | 69 (15.9) |
| Pulse rate, mean (SD) | 110.9 (19.9) |
| Respiratory rate, mean (SD) | 30.3 (11.5) |
| Splenomegaly | |
| - Yes | 23 (30.3) |
| - No | 53 (69.7) |
| Hepatomegaly | |
| - Yes | 17 (22.4) |
| - No | 59 (77.6) |
| Hemoglobin, mean (SD) | 9.47 (2.79) |
| Leukocyte, mean (SD) | 6237.8 (2722.2) |
| Platelet, mean (SD) | 85,360 (74,296.5) |
| RDT | |
| - Yes | 43 (56.6) |
| - No | 33 (43.4) |
| Time point of severe complications | |
| - Before treatment (at presentation) | 50 (65.8) |
| - After treatment (with anti-malarial drug) | 16 (21.1) |
| - Before and after treatment | 10 (13.2) |
| Complication during treatment | |
| - Yes | 34 (44.7) |
| - No | 42 (55.3) |
| Second anti-malarial drug given | |
| - Yes | 13 (17.1) |
| - No | 63 (82.9) |
| Discharge/recovery/parasite clearance | |
| - > 7 days | 41 (65.1) |
| - ≤ 7 days | 22 (34.9) |